Skip to main content
. 2021 Aug 3;12(8):764. doi: 10.1038/s41419-021-04063-2

Fig. 6. Expression pattern and functional effects of two ANLN splicing isoforms in exosomes.

Fig. 6

A The relative expression of ANLN-201 and ANLN-210 was examined in cells and exosomes by qRT-PCR. *P < 0.05, **P < 0.01. B The expression of ANLN-201 at mRNA level was examined in SCC-9 cells and exosomes when SCC-9 cells were transfected with si-HNRNPC. C The expression of ANLN-210 at mRNA level was examined in SCC-9 cells and exosomes when cells were transfected with si-HNRNPC and/or ANLN-210 overexpression. *P < 0.05, **P < 0.01. D The representative images of exosomes. Exosomes were extracted from SCC-9 cells transfected with ANLN-210 (210 O.E.) or exosomes were electrotransfected with ANLN-210 (210 E.T.). E Exosomal markers HSP70, CD63, and TSG101 were immunblotted in isolated exosomes. Calnexin which was expressing in cell lysates was used as the control. F The relative expression of ANLN-210 was examined in control, 210 O.E Exo. and 210 E.T. Exo groups. G Cell proliferation was performed in SCC-9 cell and HepG2 cells with the following treatment. PBS, exosomes derived from ANLN-sgRNA cells (Control Exo), exosomes derived from cells transfected with ANLN-210 (210 O.E. Exo), and exosomes electrotransfected with ANLN-210 (210 E.T. Exo). H Cell migration was analyzed in SCC-9 cells treated with the following treatment (PBS, Control Exo, 210 O.E. Exo, and 210 E.T. Exo).